Dopamine Plasma Membrane Transport Proteins
"Dopamine Plasma Membrane Transport Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of dopaminergic neurons. They remove DOPAMINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS and are the target of DOPAMINE UPTAKE INHIBITORS.
Descriptor ID |
D050483
|
MeSH Number(s) |
D12.776.157.530.450.625.124 D12.776.157.530.562.374.500.500 D12.776.157.530.937.500 D12.776.543.585.450.625.124 D12.776.543.585.562.374.500.500 D12.776.543.585.937.500
|
Concept/Terms |
Dopamine Plasma Membrane Transport Proteins- Dopamine Plasma Membrane Transport Proteins
- Dopamine Transporter
- Transporter, Dopamine
- SLC6A3 Protein
- Protein, SLC6A3
- Solute Carrier Family 6 (Neurotransmitter Transporter), Member 3 Protein
- Dopamine Transporter Proteins
- Transporter Proteins, Dopamine
- Dopamine Carriers
- Carriers, Dopamine
- DAT Dopamine Transporter Proteins
- Neurotransmitter Transport Proteins, Dopamine-Specific
- Neurotransmitter Transport Proteins, Dopamine Specific
- Neurotransmitter Transporters, Dopamine-Specific
- Dopamine-Specific Neurotransmitter Transporters
- Neurotransmitter Transporters, Dopamine Specific
- Transporters, Dopamine-Specific Neurotransmitter
- DAT Dopamine Transporter
- Dopamine Transporter, DAT
- Transporter, DAT Dopamine
- Dopamine Plasma Membrane Transporter Proteins
|
Below are MeSH descriptors whose meaning is more general than "Dopamine Plasma Membrane Transport Proteins".
Below are MeSH descriptors whose meaning is more specific than "Dopamine Plasma Membrane Transport Proteins".
This graph shows the total number of publications written about "Dopamine Plasma Membrane Transport Proteins" by people in this website by year, and whether "Dopamine Plasma Membrane Transport Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1998 | 0 | 4 | 4 |
1999 | 0 | 1 | 1 |
2000 | 0 | 3 | 3 |
2004 | 0 | 1 | 1 |
2005 | 0 | 4 | 4 |
2006 | 1 | 1 | 2 |
2008 | 2 | 0 | 2 |
2012 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
2015 | 2 | 1 | 3 |
2018 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
2022 | 0 | 2 | 2 |
2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dopamine Plasma Membrane Transport Proteins" by people in Profiles.
-
Social setting interacts with hyper dopamine to boost the stimulant effect of ethanol. Addict Biol. 2024 06; 29(6):e13420.
-
Dopaminergic dysfunction in the left putamen of patients with major depressive disorder. J Affect Disord. 2024 Jul 15; 357:107-115.
-
Trial of Prasinezumab in Early-Stage Parkinson's Disease. N Engl J Med. 2022 08 04; 387(5):421-432.
-
Pilot Study for Correlation of Heart Rate Variability and Dopamine Transporter Brain Imaging in Patients with Parkinsonian Syndrome. Sensors (Basel). 2022 Jul 05; 22(13).
-
Pharmacogenetic role of dopamine transporter (SLC6A3) variation on response to disulfiram treatment for cocaine addiction. Am J Addict. 2019 07; 28(4):311-317.
-
Mechanisms Underlying Microbial-Mediated Changes in Social Behavior in Mouse Models of Autism Spectrum Disorder. Neuron. 2019 01 16; 101(2):246-259.e6.
-
ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders. Clin Nucl Med. 2017 Nov; 42(11):847-852.
-
The relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord. 2016 Jan; 22 Suppl 1:S162-5.
-
Dopamine transporter imaging in essential tremor with and without parkinsonian features. J Neural Transm (Vienna). 2015 Nov; 122(11):1515-21.
-
Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders. Pharmacogenet Genomics. 2015 Jun; 25(6):296-304.